Summary:
A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter, Phase 2 Study To Evaluate The Efficacy And Safety Of Lorundrostat In Subjects With Uncontrolled Hypertension On A Standardized Medication Regimen
Qualified Participants Must:
• 18 years or older
•
BMI must be between 18-40 kg/m2
•
Current blood pressure while on your antihypertensive medication must be at least 140/90 or higher
Qualified Participants May Receive:
Preliminary Assessment at No Cost
No Cost Medication
Compensation for time and travel
No Cost Lab Work
Possible Hypertension Relief